Home
Learn More
Features & Pricing
Success Stories
Contact Us
Search Archives
PRWeb Direct
Submit Release
September 8, 2008
 
Industry Categories  
News by Country  
News by MSA  
Todays News  
Browse by Day  
PR Trackbacks™  
Featured Videos  
ViewNews™  
eBook Digests  
RSS  
PRWeb, a leader in online news and press release distribution, has been used by more than 40,000 organizations of all sizes to increase the visibility of their news, improve their search engine rankings and drive traffic to their Web site.
 
All Press Releases for October 7, 2005 Subscribe to this News Feed      
 

Autism Research Study in Phoenix and Tucson Areas

Researchers at Southwest College of Naturopathic Medicine are investigating heavy metal toxicity and autism in an upcoming chelation study.

Tempe, AZ (PRWEB) October 7, 2005 -- With autism spectrum disorders affecting about 1 in 166 children in the United States, researchers are scurrying to discover causes and treatments. The effects of heavy metals on autism are currently unknown.

Researchers at Southwest College of Naturopathic Medicine (SCNM) are investigating heavy metal toxicity and autism in an upcoming chelation study. The study, “DMSA Treatment of Children with Autism and Heavy Metal Toxicity” will be led by Matthew Baral, N.D., Assistant Professor of Pediatric Medicine at SCNM. The team of researchers, including James B. Adams, Ph.D., Adjunct Professor in the Division of Basic Medical Sciences at SCNM, Walter Crinnion, N.D., Director of the Environmental Medicine Center of Excellence at SCNM, and Sanford Newmark, M.D., from the Center for Pediatric Integrative Medicine in Tucson, AZ will begin enrolling participants in this two-part research study in October 2005.

To participate in this study, individuals must be diagnosed with autism spectrum disorder and be between the ages of 3-8 years old. The study will be conducted in two phases. In Phase I, participants will receive 2,3-dimercaptosuccinic acid (DMSA) and be evaluated for presence of toxic heavy metals. Participants with heavy metals will receive DMSA or a placebo in Phase II, a double-blind, placebo controlled trial. DMSA is a FDA-approved medication for treating lead poisoning. Some of the participants will also receive glutathione, an antioxidant naturally produced by the body. The study is sponsored by the Wallace Foundation and will be conducted at Southwest College of Naturopathic Medicine.

Parents interested in the study can call Southwest College of Naturopathic Medicine at 480-858-9643 extension 520 or email m.baral@scnm.edu.

If you are an accredited member of the media and would like further information or to request an interview, please contact: Robyn Mulia at 480-858-9100 ext. 224.

About Southwest College of Naturopathic Medicine
Located in Tempe, Arizona., and founded in 1993, Southwest College of Naturopathic Medicine is an accredited higher learning institution. It offers a four-year medical program that trains students to become primary care physicians. Naturopathic medicine emphasizes the body’s innate ability to self-heal. It draws on a rich history of natural, nontoxic therapies in combination with current medical advances. The scope of practice includes all aspects of family and primary care using integrative modalities such as acupuncture, homeopathy, clinical nutrition, botanical medicine, manipulation, and pharmacology. For more information, visit www.scnm.edu.

###

OPTIONS
Printer Friendly Version
Email this story to a colleague
CONTACT INFORMATION
Robyn Mulia
SOUTHWEST COLLEGE OF NATUROPATHIC MEDICINE
480-222-9224
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your login.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these releases. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright